This paper is in the following e-collection/theme issue:

Innovations and Technology in Cancer Care (405) Breast Cancer (201) Patient-Reported Outcome Measures (PROMs) (275) Cancer Survivorship (252) Research Instruments, Questionnaires, and Tools (545) Questionnaires and Research Instruments for Cancer Patients (16)

Published on in Vol 7, No 4 (2021): Oct-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/25776, first published .
Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study

Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study

Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study

Authors of this article:

Katharina Brusniak1 Author Orcid Image ;   Manuel Feisst2 Author Orcid Image ;   Linda Sebesteny1 Author Orcid Image ;   Andreas Hartkopf3 Author Orcid Image ;   Joachim Graf3, 4 Author Orcid Image ;   Tobias Engler3, 4 Author Orcid Image ;   Andreas Schneeweiss5, 6 Author Orcid Image ;   Markus Wallwiener1 Author Orcid Image ;   Thomas Maximilian Deutsch1 Author Orcid Image
Article Authors Cited by (5) Tweetations (3) Metrics

Katharina Brusniak   1 ;   Manuel Feisst   2 , MSc ;   Linda Sebesteny   1 ;   Andreas Hartkopf   3 , Prof Dr med ;   Joachim Graf   3, 4 , MA, MSc ;   Tobias Engler   3, 4 , Dr med ;   Andreas Schneeweiss   5, 6 , Prof Dr med ;   Markus Wallwiener   1 , Prof Dr med ;   Thomas Maximilian Deutsch   1 , Dr med

1 Department of Gynecology and Obstetrics, University Hospital Heidelberg, Heidelberg, Germany

2 Institute of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany

3 Department of Women’s Health, University Hospital Tübingen, Tübingen, Germany

4 Department of Midwifery Science, Institute for Health Sciences, University Hospital Tübingen, Tübingen, Germany

5 Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg, Germany

6 German Cancer Research Center, Heidelberg, Germany

Corresponding Author: